ClinicalTrials.Veeva

Menu

Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms

H

Huda Ahmed Abdelsabour Abdelwahab

Status

Not yet enrolling

Conditions

B Chronic Lymphocytic Leukemia

Study type

Observational

Funder types

Other

Identifiers

NCT07337967
AUN-FOM-CP-CLPD-RETIC-2025

Details and patient eligibility

About

Reticulocyte parameters as early indicators of bone marrow erythropoietic activity in chronic B lymphoproliferative neoplasms

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

- Newly diagnosed adult patients with Chronic B LymphoPoliferative neoplasm according to WHO classification.

Exclusion criteria

1) Patients received chemotherapy.

  1. Patients with Active bleeding
  2. Patients with recent blood transfusion (less than 2 weeks).
  3. Patients on haematinics or vitamin B 12 therapy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems